Additional Phase II Data Demonstrate Improvement In Reported Symptoms – Medical News Today
In Acid Reflux Disease | On June 7th, 2009 | By thearguyAdditional Phase II Data Demonstrate Improvement In Reported Symptoms – Medical News Today
Adding AZD3355, a novel GABAB receptor agonist, to a proton pump inhibitor (PPI) in patients with Gastroesophageal Reflux Disease (GERD), resulted in a 35% reduction in the mean total number of reflux episodes 0-24 hours after dose, compared with
Weight-loss surgery, depression and heartburn – WABC
NEW YORK (WABC) — There is a new technique for weight loss surgery without incisions. It’s a medical trifecta. A lot of people take heartburn medications for acid reflux disease. There are drugs like Prevasid, Prilosec or Zantac. The medications are
Drug prices rise out of reach – Rocky Mount Telegram
A year or so ago, when customers buttonholed the pharmacists at Almand’s Drug Store the questions were invariably about dosing or side effects. These days, they are almost always about cost. Can I get this as a generic? Is the co-pay really that high
Related posts:
- Technique eradicates problems in most patients with Barrett’s – Science Centric
- New Incision-Free Procedure For Severe Acid Reflux – Medical News Today
- New Incision-Free Procedure For Severe Acid Reflux – Medical News Today
- AstraZeneca submits sNDA for NEXIUM (esomeprazole magnesium) – News-Medical.Net
- Success of GERD therapy hinges on medication type and physician – News-Medical.Net
- Medical Monday: GERD – First Coast News


You must be logged in to post a comment.